Access cutting-edge chronic inflammatory demyelinating polyradiculoneuropathy treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access chronic inflammatory demyelinating polyradiculoneuropathy specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic inflammatory demyelinating polyradiculoneuropathy treatment provided free
CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the body. This leads to muscle weakness and loss of sensation in arms and legs among other symptoms. Participants with CIDP can be treated with a protein called immunoglobulin (or IG). TAK-411 is a special type of immune globu
Sponsor: Takeda
Check if you qualify for this chronic inflammatory demyelinating polyradiculoneuropathy clinical trial in Rochester, MN
If you're searching for chronic inflammatory demyelinating polyradiculoneuropathy treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyradiculoneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.